Home Endocrinology & Hormones Glucocorticoid Receptor agonist Mometasone furoate For research use only.

Mometasone furoate

Synonyms: SCH-32088,mometasone 17-furoate

Mometasone Furoate (SCH-32088,mometasone 17-furoate) is a glucocorticoid receptor agonist, used topically to reduce inflammation of the skin or in the airways.

Mometasone furoate Chemical Structure

Mometasone furoate Chemical Structure

CAS No. 83919-23-7

Purity & Quality Control

Mometasone furoate Related Products

Biological Activity

Description Mometasone Furoate (SCH-32088,mometasone 17-furoate) is a glucocorticoid receptor agonist, used topically to reduce inflammation of the skin or in the airways.
Targets
Glucocorticoid receptor [1]
In vitro
In vitro

Mometasone furoate efficiently suppresses production of cytokines including interleukin (IL)-4, IL-5, and interferon-gamma in anti-CD3-stimulated human CD4+ T cells. Mometasone furoate effectively inhibits the activation of Th cells including type 2 Th (Th2) in the draining LN, thus leading to the suppression of the IgE response. [1]
In Vivo
In vivo

Mometasone causes a decrease in the instances of nasal rubbing and an inhibition of this response is observed during the treatment period in rats. [2] Mometasone (3 mg/kg) inhibits the increased airway sensitivity to aerosolized methacholine at the highest dose tested in mice. Mometasone, given an hour after the last allergen challenge, dose-dependently inhibits the allergen-induced increase in Penh with about a 10-fold loss of potency when compared with the pre-challenge treatment schedule. [3] Mometasone furoate (0.02%) and fluticasone propionate (0.1%) significantly inhibits the increase of antigen-induced nasal rubbing even 6 hours after topical application, indicating that both drugs have a long-lasting effect. [4] Mometasone furoate dose-dependently inhibits the elevated eosinophil numbers in the bronchoalveolar lavage fluid and lung tissues of sensitized, ovalbumin challenged mice. Mometasone furoate (33 mg/kg) reduces the percentage of CD44+ T-helper cells (activated/memory cells) to the levels observed in non-sensitized, ovalbumin-challenged mice. [5]
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT02967731 Completed
Chronic Sinusitis
Lyra Therapeutics
 June 6 2017 Phase 1
NCT01894503 Completed
Chronic Sinusitis
Intersect ENT
 June 2013 Phase 2
NCT01702103 Unknown status
Nasal Obstruction|Sneezing|Itching
PH&T S.p.A.
 October 2012 Phase 3

Chemical Information & Solubility

Molecular Weight 521.43 Formula

C27H30Cl2O6
CAS No. 83919-23-7 SDF Download Mometasone furoate SDF
Smiles CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 40 mg/mL ( (76.71 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : Insoluble

Ethanol : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Mometasone furoate | Mometasone furoate ic50 | Mometasone furoate price | Mometasone furoate cost | Mometasone furoate solubility dmso | Mometasone furoate purchase | Mometasone furoate manufacturer | Mometasone furoate research buy | Mometasone furoate order | Mometasone furoate mouse | Mometasone furoate chemical structure | Mometasone furoate mw | Mometasone furoate molecular weight | Mometasone furoate datasheet | Mometasone furoate supplier | Mometasone furoate in vitro | Mometasone furoate cell line | Mometasone furoate concentration | Mometasone furoate nmr